Offerings - Offering: 1 |
Nov. 11, 2025
USD ($)
shares
|
|---|---|
| Offering: | |
| Fee Previously Paid | false |
| Other Rule | true |
| Security Type | Equity |
| Security Class Title | Ordinary Shares, no par value |
| Amount Registered | shares | 4,000,000,000 |
| Proposed Maximum Offering Price per Unit | 0.0003 |
| Maximum Aggregate Offering Price | $ 1,200,000.00 |
| Fee Rate | 0.01381% |
| Amount of Registration Fee | $ 165.72 |
| Offering Note | Deposited as American Depositary Shares (“ADSs”), evidenced by American Depositary Receipts, issuable upon deposit of the ordinary shares, no par value (“Ordinary Shares”), of Scinai Immunotherapeutics Ltd. (the “Company”) registered hereby are registered on a separate registration statement on Form F-6 (File No. 333-203333). Each ADS represents four thousand (4,000) Ordinary Shares. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, this registration statement shall also cover any additional Ordinary Shares that become issuable under the Company’s 2018 Share Option Plan, as amended by reason of any stock dividend, stock split, or other similar transaction. Estimated solely for purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act and based on the average of the high and low prices of the Company's ADSs reported on the NASDAQ Capital Market on November 7, 2025, which date is within five business days of the filing of this Registration Statement on Form S-8. |